Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alan E. Schuster
Observed names:
A Schuster,
A. Schuster,
Alan Schuster
Institution:
Bristol-Myers Squibb (United States)
Observed institutions:
Princeton University,
Bristol-Myers Squibb (United States)
OpenAlex ID:
A5038698373
Apixaban, an oral, direct factor X a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
2012
·
Charles Frost
, Jessie Wang
, et al.
·
British Journal of Clinical Pharmacology
·
370
PDF
Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor X a inhibitor, in healthy subjects
2013
·
Charles Frost
, Sunil Nepal
, et al.
·
British Journal of Clinical Pharmacology
·
285
PDF
Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard
2003
·
Mohammed Jemal
, Alan Schuster
, et al.
·
Rapid Communications in Mass Spectrometry
·
197
Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor X a inhibitor
2014
·
Charles E. Frost
, Wonkyung Byon
, et al.
·
British Journal of Clinical Pharmacology
·
160
PDF
Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans
2009
·
Donglu Zhang
, Kan He
, et al.
·
Drug Metabolism and Disposition
·
106
Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban
2015
·
Charles E. Frost
, Yan Song
, et al.
·
Clinical Pharmacokinetics
·
95
PDF
Formulation of Solid Dosage Forms to Overcome Gastric pH Interaction of the Factor Xa Inhibitor, BMS-561389
2006
·
Sherif I. Farag Badawy
, David B. Gray
, et al.
·
Pharmaceutical Research
·
67
LC–MS/MS Determination of Apixaban (BMS-562247) and its Major Metabolite in Human Plasma: an Application of Polarity Switching and Monolithic HPLC Column
2014
·
Janice Pursley
, Jim X Shen
, et al.
·
Bioanalysis
·
57
Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects
2018
·
Wonkyung Byon
, Sunil Nepal
, et al.
·
The Journal of Clinical Pharmacology
·
52
Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography–tandem mass spectrometry following automated solid-phase extraction
2003
·
A Schuster
, S Burzawa
, et al.
·
Journal of Chromatography B
·
43
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects
2013
·
Charles Frost
, Yimin Cui
, et al.
·
Clinical Pharmacology Advances and Applications
·
36
PDF
Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation
2000
·
Mohammed Jemal
, Mike Huang
, et al.
·
Rapid Communications in Mass Spectrometry
·
32
The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
2017
·
Charles Frost
, Yan Song
, et al.
·
Clinical Pharmacology Advances and Applications
·
22
PDF
Development of a validated liquid chromatography tandem mass spectrometry assay for a PEGylated adnectin in cynomolgus monkey plasma using protein precipitation and trypsin digestion
2013
·
Michelle L. Dawes
, Huidong Gu
, et al.
·
Journal of Chromatography B
·
22
Application of a design of experiment approach in the development of a sensitive bioanalytical assay in human plasma
2012
·
Michelle L. Dawes
, James S. Bergum
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
11
A preliminary pharmacokinetic and pharmacodynamic evaluation of the HIV protease inhibitor BMS-232632 in a protease inhibitor-naive HIV+ population
2000
·
O apos
, Elise Mara
, et al.
·
8
Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects
1997
·
Nuggehally R. Srinivas
, Wen Chyi Shyu
, et al.
·
Clinical Pharmacology & Therapeutics
·
7
Dried blood spot analysis without dilution: Application to the LC–MS/MS determination of BMS-986001 in rat dried blood spot
2015
·
Long Yuan
, Alan Schuster
, et al.
·
Journal of Chromatography B
·
5
Manual and automated determination of and its metabolite (E)-5-(2-bromovinyl)uracil in urine
1995
·
Daisy B. Whigan
, Alan E. Schuster
·
Journal of Chromatography B Biomedical Sciences and Applications
·
5
High-Performance Liquid Chromatographic - Ultraviolet Assay for the Simultaneous Quantitation of BMS-181101 and its Putative Hydroxy Metabolites in Rat and Monkey Plasma
1996
·
V. R. Shah
, N. R. Srinivas
, et al.
·
Biomedical Chromatography
·
3
High-performance liquid chromatographic–electrochemical assay for the quantitation of BMS-181885 in monkey plasma
1998
·
N.R Srinivas
, V.R Shah
, et al.
·
Journal of Chromatography B Biomedical Sciences and Applications
·
2
Effects of Age, Gender and Diurnal Variation on the Steady-State Pharmacokinetics (PK) of BMS-181101
1996
·
W.C. Shyu
, N.R. Srinivas
, et al.
·
Clinical Pharmacology & Therapeutics
·
2
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]
2014
·
Charles Frost
, Yimin Cui
, et al.
·
Clinical Pharmacology Advances and Applications
PDF
Show more works
View as search
Works count:
23
Citation count:
1,587
H-index:
14
I10-index:
15
Year
Topic
Type
